Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
Completed
131 enrolled 8 charts
STAR-T
Completed
818 enrolled
HCC
Completed
166 enrolled
DELINOR
Completed
5,279 enrolled 10 charts
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma
Completed
188 enrolled
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Completed
106 enrolled
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Completed
90 enrolled
COMET
Completed
510 enrolled
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Completed
30 enrolled
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
Completed
3,003 enrolled
Argo
Completed
111 enrolled 14 charts
Psychometric Properties of the EORTC QLQ-LC29
Completed
523 enrolled
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
Completed
76 enrolled
REBECA
Completed
50 enrolled
AVACONT
Completed
300 enrolled
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
Completed
351 enrolled
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Completed
719 enrolled
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Completed
201 enrolled
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Completed
4,278 enrolled
CIRCUS
Completed
103 enrolled
AVALANCHE
Completed
150 enrolled
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Completed
90 enrolled
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Completed
180 enrolled
PICASSO
Completed
210 enrolled 22 charts
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
Completed
68 enrolled 8 charts
Bevacizumab in Metastatic Renal Cancer
Completed
365 enrolled 9 charts
Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
Completed
996 enrolled 14 charts
ENCOURAGE
Completed
500 enrolled
CONCERT
Completed
765 enrolled 8 charts
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Completed
28 enrolled 7 charts
BevaRet
Completed
20 enrolled
Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)
Completed
201 enrolled 11 charts
Hepatic Monitoring for Pazopanib
Completed
1 enrolled
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
Completed
31 enrolled
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
Completed
1 enrolled
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)
Completed
1 enrolled
ANGIOMET
Completed
200 enrolled
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
Completed
7 enrolled
First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
Completed
15 enrolled